EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity

Sara P S P Moura iD, Silvia Marín iD, Ismael Rufino iD, Rita C Guedes iD, Marta Cascante iD, Jorge A R Salvador iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sara P S P Moura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal. Hauptthemen laut MEDLINE: Abietanes, Antineoplastic Agents, Molecular Docking Simulation, Urea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Portuguese Foundation for Science and Technology, European Regional Development Fund, Agència de Gestió d'Ajuts Universitaris i de Recerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel carnosic acid 1 derivatives incorporating urea moieties at the C-20 position was synthesized and evaluated for their antiproliferative activity against the HCT116 colorectal cancer cell line. Most derivatives demonstrated enhanced antiproliferative activity compared to that of carnosic acid 1. The most promising derivatives were tested in other colorectal cancer cell lines (SW480, SW620, and Caco-2), melanoma (A375), and pancreatic cancer (MiaPaca-2). Derivative 14 consistently demonstrated the highest activity across all tested cancer cell lines, showing selectivity for cancer cells over normal cells. Further investigation of the mechanism of action in SW480 cells revealed that compound 14 induced cell cycle arrest at the G0/G1 phase by downregulating CDK4 and CDK6. Molecular docking studies revealed that compound 14 established several interactions with key residues in the active site of CDK6. Additionally, compound 14 also reduced ROS production. In summary, our results strongly indicate that compound 14 has potential as a lead compound in the development of innovative anticancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AbietanesAntineoplastic AgentsMolecular Docking SimulationUreaCell ProliferationDrug DesignCyclin-Dependent Kinase 6HumansCell Line, TumorCyclin-Dependent Kinase 4Reactive Oxygen SpeciesCell Cycle CheckpointsHCT116 CellsDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

CDK4CDK6abietaneanticancer activitycarnosic acidcell cycle arrestditerpenoidsreactive oxygen species (ROS)urea derivatives

Substanzen

AbietanessalvinAntineoplastic AgentsUreaCyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4Reactive Oxygen SpeciesCDK6 protein, humanCDK4 protein, human

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
  • Center for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal.
  • Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisboa, 1649-003 Lisboa, Portugal.

ORCID-Profile: Sara P S P Moura, Silvia Marín, Ismael Rufino, Rita C Guedes, Marta Cascante, Jorge A R Salvador

Förderung

  • Portuguese Foundation for Science and Technology
  • European Regional Development Fund
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Centro de Investigación Biomédica en Red en Enfermedades hepáticas y digestivas
  • FCT—Fundação para a Ciência e a Tecnologia (Portuguese Foundation for Science and Technology)
  • FCT
  • Universidade de Coimbra
  • Portuguese national funds

Zitieren

APA

Moura, S. P. S. P., Marín, S., Rufino, I., Guedes, R. C., Cascante, M., & Salvador, J. A. R. (2024). Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413332

Vancouver

Moura SPSP, Marín S, Rufino I, Guedes RC, Cascante M, Salvador JAR. Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413332

BibTeX
@article{Moura2024,
  author = {Moura, Sara P S P and Marín, Silvia and Rufino, Ismael and Guedes, Rita C and Cascante, Marta and Salvador, Jorge A R},
  title = {Design, Synthesis, and Biological Evaluation of Novel Urea-Containing Carnosic Acid Derivatives with Anticancer Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413332}
}
Kostenlos starten →